• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病中内源性类吗啡化合物免疫反应性增加。

Endogenous morphine-like compound immunoreactivity increases in parkinsonism.

机构信息

University of Bordeaux, Institut des Maladies Neurodegeneratives, Bordeaux, France.

出版信息

Brain. 2011 Aug;134(Pt 8):2321-38. doi: 10.1093/brain/awr166. Epub 2011 Jul 8.

DOI:10.1093/brain/awr166
PMID:21742735
Abstract

Morphine is endogenously synthesized in the central nervous system and endogenous dopamine is thought to be necessary for endogenous morphine formation. As Parkinson's disease results from the loss of dopamine and is associated with central pain, we considered how endogenous morphine is regulated in the untreated and l-DOPA-treated parkinsonian brain. However, as the cellular origin and overall distribution of endogenous morphine remains obscure in the pathological adult brain, we first characterized the distribution of endogenous morphine-like compound immunoreactive cells in the rat striatum. We then studied changes in the endogenous morphine-like compound immunoreactivity of medium spiny neurons in normal, Parkinson's disease-like and l-DOPA-treated Parkinson's disease-like conditions in experimental (rat and monkey) and human Parkinson's disease. Our results reveal an unexpected dramatic upregulation of neuronal endogenous morphine-like compound immunoreactivity and levels in experimental and human Parkinson's disease, only partially normalized by l-DOPA treatment. Our data suggest that endogenous morphine formation is more complex than originally proposed and that the parkinsonian brain experiences a dramatic upregulation of endogenous morphine immunoreactivity. The functional consequences of such endogenous morphine upregulation are as yet unknown, but based upon the current knowledge of morphine signalling, we hypothesize that it is involved in fatigue, depression and pain symptoms experienced by patients with Parkinson's disease.

摘要

吗啡在中枢神经系统内源性合成,内源性多巴胺被认为是内源性吗啡形成所必需的。由于帕金森病是由多巴胺的丧失引起的,并与中枢疼痛有关,我们考虑了未治疗和 l-DOPA 治疗的帕金森病大脑中内源性吗啡是如何调节的。然而,由于内源性吗啡样化合物在病理性成年大脑中的细胞起源和整体分布仍然不清楚,我们首先描述了内源性吗啡样化合物免疫反应性细胞在大鼠纹状体中的分布。然后,我们研究了正常、帕金森病样和 l-DOPA 治疗的帕金森病样条件下中脑多巴胺能神经元内源性吗啡样化合物免疫反应性的变化,这些条件在实验(大鼠和猴子)和人类帕金森病中存在。我们的结果显示,实验和人类帕金森病中神经元内源性吗啡样化合物免疫反应性和水平出人意料地显著上调,仅部分通过 l-DOPA 治疗得到正常化。我们的数据表明,内源性吗啡的形成比最初提出的更为复杂,帕金森病大脑经历了内源性吗啡免疫反应性的显著上调。这种内源性吗啡上调的功能后果尚不清楚,但根据目前对吗啡信号的了解,我们假设它与帕金森病患者所经历的疲劳、抑郁和疼痛症状有关。

相似文献

1
Endogenous morphine-like compound immunoreactivity increases in parkinsonism.帕金森病中内源性类吗啡化合物免疫反应性增加。
Brain. 2011 Aug;134(Pt 8):2321-38. doi: 10.1093/brain/awr166. Epub 2011 Jul 8.
2
Effect of repeated L-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat.重复给予左旋多巴、溴隐亭或利苏瑞ide对6-羟基多巴胺损伤大鼠纹状体中前脑啡肽原-A和前脑啡肽原-B mRNA水平的影响。
Exp Neurol. 1999 Feb;155(2):204-20. doi: 10.1006/exnr.1998.6996.
3
Dopamine D3 receptor stimulation underlies the development of L-DOPA-induced dyskinesia in animal models of Parkinson's disease.在帕金森病动物模型中,多巴胺D3受体的刺激是左旋多巴诱导的运动障碍发展的基础。
Neurobiol Dis. 2009 Aug;35(2):184-92. doi: 10.1016/j.nbd.2008.11.010. Epub 2008 Dec 9.
4
Salicylic acid protects against chronic L-DOPA-induced 6-OHDA generation in experimental model of parkinsonism.水杨酸可预防帕金森病动物模型中慢性 L-DOPA 诱导的 6-OHDA 生成。
Brain Res. 2010 Jul 16;1344:192-9. doi: 10.1016/j.brainres.2010.05.010. Epub 2010 May 12.
5
Melatonin inhibits 6-hydroxydopamine production in the brain to protect against experimental parkinsonism in rodents.褪黑素抑制大脑中 6-羟多巴胺的产生,以预防啮齿动物实验性帕金森病。
J Pineal Res. 2009 Nov;47(4):293-300. doi: 10.1111/j.1600-079X.2009.00713.x. Epub 2009 Oct 1.
6
Neuroprotective effect of L-dopa on dopaminergic neurons is comparable to pramipexol in MPTP-treated animal model of Parkinson's disease: a direct comparison study.在MPTP诱导的帕金森病动物模型中,左旋多巴对多巴胺能神经元的神经保护作用与普拉克索相当:一项直接比较研究。
J Neurochem. 2009 Nov;111(4):1042-50. doi: 10.1111/j.1471-4159.2009.06381.x. Epub 2009 Sep 16.
7
The neurobehavioral changes induced by bilateral rotenone lesion in medial forebrain bundle of rats are reversed by L-DOPA.左旋多巴可逆转大鼠内侧前脑束双侧鱼藤酮损伤所诱导的神经行为变化。
Behav Brain Res. 2004 May 5;151(1-2):117-24. doi: 10.1016/j.bbr.2003.08.014.
8
Altered D(1) dopamine receptor trafficking in parkinsonian and dyskinetic non-human primates.帕金森病和异动症非人类灵长类动物中D(1)多巴胺受体转运的改变
Neurobiol Dis. 2007 May;26(2):452-63. doi: 10.1016/j.nbd.2007.02.001. Epub 2007 Feb 9.
9
Loss of D3 receptors in the zitter mutant rat is not reversed by L-dopa treatment.左旋多巴治疗不能逆转颤抖突变大鼠中D3受体的丧失。
Exp Neurol. 2004 May;187(1):178-89. doi: 10.1016/j.expneurol.2004.01.012.
10
Identification of brain-derived neurotrophic factor in nestin-expressing astroglial cells in the neostriatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice.在1-甲基-4-苯基-1,2,3,6-四氢吡啶处理的小鼠新纹状体中,巢蛋白表达的星形胶质细胞中脑源性神经营养因子的鉴定。
Neuroscience. 2004;126(4):941-53. doi: 10.1016/j.neuroscience.2004.04.020.

引用本文的文献

1
Discovering Hair Biomarkers of Alzheimer's Disease Using High Resolution Mass Spectrometry-Based Untargeted Metabolomics.利用基于高分辨率质谱的非靶向代谢组学发现阿尔茨海默病的头发生物标志物。
Molecules. 2023 Feb 25;28(5):2166. doi: 10.3390/molecules28052166.
2
Neuroprotection or Neurotoxicity of Illicit Drugs on Parkinson's Disease.非法药物对帕金森病的神经保护或神经毒性作用
Life (Basel). 2020 Jun 11;10(6):86. doi: 10.3390/life10060086.
3
Vector-mediated l-3,4-dihydroxyphenylalanine delivery reverses motor impairments in a primate model of Parkinson's disease.
载体介导的 l-3,4-二羟苯丙氨酸递送可逆转帕金森病灵长类动物模型的运动障碍。
Brain. 2019 Aug 1;142(8):2402-2416. doi: 10.1093/brain/awz176.
4
The levels of the NMDA receptor co-agonist D-serine are reduced in the substantia nigra of MPTP-lesioned macaques and in the cerebrospinal fluid of Parkinson's disease patients.在 MPTP 损伤的猕猴黑质和帕金森病患者的脑脊液中,NMDA 受体共激动剂 D-丝氨酸的水平降低。
Sci Rep. 2019 Jun 20;9(1):8898. doi: 10.1038/s41598-019-45419-1.
5
Dopamine in the Brain: Hypothesizing Surfeit or Deficit Links to Reward and Addiction.大脑中的多巴胺:关于过量或不足与奖赏及成瘾之间联系的假说
J Reward Defic Syndr. 2015;1(3):95-104. doi: 10.17756/jrds.2015-016. Epub 2015 Oct 23.
6
Cytochrome P450 3A Enzymes Catalyze the O6-Demethylation of Thebaine, a Key Step in Endogenous Mammalian Morphine Biosynthesis.细胞色素P450 3A酶催化蒂巴因的O6-去甲基化反应,这是内源性哺乳动物吗啡生物合成的关键步骤。
J Biol Chem. 2015 Aug 14;290(33):20200-10. doi: 10.1074/jbc.M115.665331. Epub 2015 Jul 8.
7
Targeting β-arrestin2 in the treatment of L-DOPA-induced dyskinesia in Parkinson's disease.靶向β-抑制蛋白2治疗帕金森病左旋多巴诱导的异动症
Proc Natl Acad Sci U S A. 2015 May 12;112(19):E2517-26. doi: 10.1073/pnas.1502740112. Epub 2015 Apr 27.
8
The UDP-glucuronosyltransferases of the blood-brain barrier: their role in drug metabolism and detoxication.血脑屏障的 UDP-葡糖醛酸基转移酶:它们在药物代谢和解毒中的作用。
Front Cell Neurosci. 2014 Oct 28;8:349. doi: 10.3389/fncel.2014.00349. eCollection 2014.
9
Astrocytosis in parkinsonism: considering tripartite striatal synapses in physiopathology?帕金森病中的星形胶质细胞增生:在生理病理学中考虑三联体纹状体突触?
Front Aging Neurosci. 2014 Sep 24;6:258. doi: 10.3389/fnagi.2014.00258. eCollection 2014.
10
Acute morphine treatments alleviate tremor in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys.急性吗啡治疗可减轻1-甲基-4-苯基-1,2,3,6-四氢吡啶处理的猴子的震颤。
PLoS One. 2014 Feb 10;9(2):e88404. doi: 10.1371/journal.pone.0088404. eCollection 2014.